From The Stage

Platform Spotlight: ProteinSimple Ella™ for Accurate and Reproducible Multiplex Biomarker Analysis

Dr. Afshin Safavi
Posted by Dr. Afshin Safavi / / BioAgilytix Insight, Bioanalytical Platforms, Biomarkers

When assessing biomarkers for multifactorial diseases, we ideally want to assess multiple analytes in the same experiment. That is where the value of multiplex biomarker analysis comes in – but this method also inherently creates potential challenges with cross-reactivity. We discuss how the ProteinSimple Ella platform enables multiplexing with excellent assay reproducibility, and how it can benefit studies with low sample volumes.

BioAgilytix Team Q&A: Meet David Rusnak, Director of Laboratory Systems and Automation at BioAgilytix

Jim Datin
Posted by Jim Datin / / BioAgilytix Insight, CRO Selection

In this Q&A session we talk to David Rusnak, one of the first 3 employees to join BioAgilytix when it was founded 10 years ago and currently our Director of Laboratory Systems and Automation, to learn more about his experience growing with the organization from its very start – and what still keeps him excited to come to work each day.

BioAgilytix Team Q&A: Meet Gabi Schewe, Lab Manager at BioAgilytix Europe

Dr. Arno Kromminga
Posted by Dr. Arno Kromminga / / BioAgilytix Insight, CRO Selection

In this Q&A session, we speak to longtime BioAgilytix Europe team member Gabi Schewe – who has been with the company since its founding as IPM Biotech in 1996 – to hear about the exciting and historic scientific advancements she has been part of with the company and what she believes has made its long-term success possible.

Key Takeaways from 2018’s AAPS PharmSci 360

Dr. Dominique Gouty
Posted by Dr. Dominique Gouty / / BioAgilytix Insight, Industry Update

Our team had the opportunity to both attend and present at a number of content-rich sessions during AAPS’ 2018 PharmSci 360 event. These conversations will have a direct impact on our own work moving forward, and we wanted to summarize and share a few of the key takeaways we found most interesting and valuable.